Ludwig Enterprises, Inc. operates as a genomic technology and health related company in the United States. The company engages in the developing of products that use inflammatory genetic markers to assess the occurrence of inflammation and inflammation related diseases, as well as monitor treatment responses. It also provides Revealia for Life Home Test Kits, that identify the potential to develop chronic inflammatory diseases, such as cancer and heart disease. In addition, the company develop a medical machine learning artificial intelligence technology that uses mRNA inflammatory language to capture an inflammatory snapshot of disease and the body's response to treatment. Ludwig Enterprises, Inc. was incorporated in 2006 and is based in Miami, Florida.